Funded Tech Companies
Emvena Therapeutics
Wondering who provided funding to Emvena Therapeutics? Penn-BioNTech Innovative Therapeutics Seed Fund (PxB Fund) joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Emvena Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Undisclosed
Philadelphia, PA Undisclosed
USA
Philadelphia, PA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Emvena Therapeutics is a biotechnology company developing placenta-targeted mRNA medicines for serious maternal and fetal conditions. Founded in 2026 based on research from the University of Pennsylvania, our lead program focuses on preeclampsia, a serious pregnancy complication with no approved therapy that treats the underlying disease. By restoring healthy blood vessel growth in the placenta, we aim to address the condition at its source and move beyond symptom management, with the potential to improve outcomes for both mother and baby.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/4/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Young Kwon
VP - R & D
Hannah Safford
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs